Part 3: Newer therapies for ANCA-associated vasculitis

D. Jayne

Renal Unit, Addenbrooke’s Hospital, Cambridge, UK.

Key words

Vasculitis, therapy, immunosuppression, mycophenolate mofetil, deoxyspergualin, B cell, rituximab.

Please address correspondence to: David Jayne MD FRCP, Consultant in Nephrology and Vasculitis, Box 118, Renal Unit, Addenbrooke’s Hospital, Cambridge CB2 2QQ, United Kingdom.

E-mail: dj106@cam.ac.uk

Clin Exp Rheumatol 2007; 25 (Suppl. 44): S77-S79.

© Clinical and Experimental Rheumatology 2007.